Uveitis associated with human immunodeficiency virus infection.
OBJECTIVE
To report uveitis associated with human immunodeficiency virus (HIV) infection and to suggest guidelines for treatment.


METHODS
Six HIV-seropositive patients (10 eyes) with anterior or posterior uveitis or both were evaluated. After ineffective prolonged treatment with systemic and topical corticosteroids, specific systemic antiretroviral therapy with zidovudine was initiated in all patients. Aqueous humor was cultured in three eyes of three patients, and vitreous humor was cultured in one eye of one patient.


RESULTS
In all 10 eyes of six patients, there was resolution of inflammation in 10 to 42 days after commencement of treatment with zidovudine (600 to 800 mg/day), despite no or minimal response to corticosteroids. Cultures of aqueous humor from three eyes of three patients and culture of vitreous humor from one eye of one patient were positive for HIV; no other organism was isolated. Systemic evaluation disclosed no other identifiable cause for the uveitis in any patient.


CONCLUSIONS
Infection with HIV appears to be a cause of uveitis. A trial of zidovudine may be warranted in HIV-seropositive patients with uveitis that is poorly responsive to corticosteroid treatment when no other cause is identified. The efficacy of other retroviral agents was not determined.
Rosberger
D F
DF
Department of Ophthalmology, The New York Hospital-Cornell Medical Center, New York, USA.
Heinemann
M H
MH
Friedberg
D N
DN
Holland
G N
GN
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D001082:Aqueous Humor / Q000821:virology; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D015828:Eye Infections, Viral; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D006679:HIV Seropositivity / Q000150:complications; D015497:HIV-1 / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D014606:Uveitis, Anterior / Q000188:drug therapy / Q000821:virology*; D015866:Uveitis, Posterior / Q000188:drug therapy / Q000821:virology*; D014822:Vitreous Body / Q000821:virology; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D015215:Zidovudine